Rafael Holdings (RFL) EBITDA Margin (2017 - 2026)
Rafael Holdings' EBITDA Margin was -3811.17% in fiscal Q3 2026 (quarter ended Apr 30, 2026), down 2194.87 percentage points from -1616.30% a year earlier and down 683.21 percentage points from the prior quarter.
Rafael Holdings (RFL) EBITDA Margin (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, Rafael Holdings' EBITDA Margin was -3696.53% through Apr 30, 2026, down 973.17 percentage points year-over-year; for FY2025 (ended Jul 31, 2025), it was -3148.42%, up 12927.25 percentage points from FY2024.
- EBITDA Margin shows a five-year change of -3014.02 percentage points (FY2020 to FY2025).
- In earlier fiscal years, EBITDA Margin was -16075.67% in FY2024 (-10711.87 pp), -5363.80% in FY2023 (+9369.13 pp), -14732.93% in FY2022 (-11225.57 pp) and -3507.36% in FY2021 (-3372.96 pp).
- Quarterly EBITDA Margin has moved between -27696.13% (fiscal Q3 2024) and -1616.30% (fiscal Q3 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in four of the last eight quarters, with an average year-over-year change of +3114.83 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was fiscal Q3 2025 (a gain of 26079.83 percentage points); the worst was fiscal Q1 2022 (a drop of 25731.12 percentage points).
- Per Business Quant data, RFL's EBITDA Margin in the three fiscal quarters before Q3 2026 was -3127.96% (Q2 2026), -4204.58% (Q1 2026) and -3632.29% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Rafael Holdings | 102.93 Mn | 108.34 Mn | 163,000.00 | -3,811.17% |
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -3,811.17% |
| Jan 31, 2026 | -3,127.96% |
| Oct 31, 2025 | -4,204.58% |
| Jul 31, 2025 | -3,632.29% |
| Apr 30, 2025 | -1,616.30% |
| Jan 31, 2025 | -8,505.19% |
| Oct 31, 2024 | -2,935.94% |
| Jul 31, 2024 | -2,289.09% |
| Apr 30, 2024 | -27,696.13% |
| Jan 31, 2024 | -4,566.18% |
| Oct 31, 2023 | -3,619.12% |
| Jul 31, 2023 | -3,813.24% |
| Apr 30, 2023 | -4,242.25% |
| Jan 31, 2023 | -6,057.14% |
| Oct 31, 2022 | -7,314.29% |
| Jul 31, 2022 | -6,985.51% |
| Apr 30, 2022 | -6,148.68% |
| Jan 31, 2022 | -2,136.49% |
| Oct 31, 2021 | -25,926.18% |
| Apr 30, 2021 | -331.11% |
Rafael Holdings EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RFL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "RFL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=RFL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();